FINDEX Inc. (TYO:3649)
Japan · Delayed Price · Currency is JPY | Market Cap | 20.34B |
| Revenue (ttm) | 5.76B |
| Net Income (ttm) | 1.15B |
| Shares Out | 24.68M |
| EPS (ttm) | 44.79 |
| PE Ratio | 18.40 |
| Forward PE | 16.08 |
| Dividend | 17.00 (2.11%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 66,900 |
| Average Volume | 69,570 |
| Open | 825.00 |
| Previous Close | 824.00 |
| Day's Range | 823.00 - 854.00 |
| 52-Week Range | 598.00 - 956.00 |
| Beta | 0.32 |
| RSI | 54.04 |
| Earnings Date | Nov 13, 2025 |
About FINDEX
FINDEX Inc. offers medical systems, office systems, and medical equipment solutions in Japan. It operates through three segments: Medical Business, Public Business, and Healthtech Business. The company provides Claio image filing system, C-Scan paper and digital document management system, DocuMaker document creation system, PDI+MoveBy referral information management system, C-Note medical record recording system, MapleNote perinatal system, REMORA electronic medical record, ID-Cam/Claio-Cam digital camera solution, UniversalSearcher medical bi... [Read more]
Financial Performance
In 2024, FINDEX's revenue was 5.84 billion, an increase of 12.52% compared to the previous year's 5.19 billion. Earnings were 1.16 billion, an increase of 9.73%.
Financial StatementsNews
PE-backed Findex set to restock coffers with $400m refinancing
Skye Capital is expected to spend the coming weeks collecting feedback from funds on the deal structure, including size and pricing.